A cross-trial comparison of single-agent ibrutinib versus chlorambucil-obinutuzumab in previously untreated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma
| Autor: | Lori Styles, Ian W. Flinn, Alessandra Tedeschi, Don A. Stevens, John G. Gribben, Devinder Gill, Viktor Fedorov, Gianluca Gaidano, Paul M. Barr, Richard Greil, David Simpson, Osnat Bairey, Jan A. Burger, Tadeusz Robak, Thomas Webb, Carol Moreno, Thomas J. Kipps, Jennifer H. Lin, Fatih Demirkan, Bertrand Anz |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Oncology
medicine.medical_specialty Cross trial Chlorambucil business.industry Chronic lymphocytic leukemia Adenine Hematology medicine.disease Antibodies Monoclonal Humanized Leukemia Lymphocytic Chronic B-Cell Lymphocytic lymphoma chemistry.chemical_compound chemistry Piperidines Obinutuzumab Internal medicine Ibrutinib medicine Humans Single agent business Online Only Articles medicine.drug |
| Zdroj: | HAEMATOLOGICA r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname |
| ISSN: | 0390-6078 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|